The Argentina inborn errors of protein metabolism (IEPM) market was valued at US$ 268.2 million in 2023 and is expected to achieve a market valuation of US$ 664.0 million by 2032. This impressive ...

Meanwhile, the positive results in PKU are a boost for Synlogic's biotherapeutic strategy, which will be tested further later this year with the readout of its phase 1 trial of homocystinuria (HCU ...